{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T21:28:31Z","timestamp":1774560511377,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008877","name":"Biosensors International Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008978","name":"Philips Oral Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008978","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ijcard.2019.11.003","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T19:15:40Z","timestamp":1573067740000},"page":"60-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12\u202fmonths: Pooled patient level analysis from BIOSOLVE II\u2013III and BIOFLOW II trials"],"prefix":"10.1016","volume":"300","author":[{"given":"Alexandre","family":"Hideo-Kajita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector M.","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kolm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viana","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcseyin","family":"Ince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Kische","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Abizaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"T\u00f6elg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Alves","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas M.","family":"Van Mieghem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Verheye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"von Birgelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evald H\u00f8j","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Haude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.11.003_bb0005","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig Lecture ESC 2014","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0010","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0015","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jcmg.2014.06.018","article-title":"Assessing bioresorbable coronary devices: methods and parameters","volume":"7","author":"Garcia-Garcia","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2019.11.003_bb0020","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable scaffolds versus metallic stents in routine PCI","volume":"376","author":"Wykrzykowska","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0025","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0735-1097(17)34638-7","article-title":"Long-term outcomes of absorb bioresorbable vascular scaffold versus second generation DES in coronary artery disease: a meta-analysis","volume":"69","author":"Nairooz","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0030","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/eurheartj\/ehw196","article-title":"Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial","volume":"37","author":"Haude","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)00447-X","article-title":"Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 months results of a prospective, multicentre, non-randomised, first-in-man trial","volume":"387","author":"Haude","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0040","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4244\/EIJ-D-17-00254","article-title":"Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III","volume":"13","author":"Haude","year":"2017","journal-title":"EuroIntervention."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001441","article-title":"Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial","volume":"8","author":"Windecker","year":"2015","journal-title":"Circ Cardiovasc Interv."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0050","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","article-title":"Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial","volume":"390","author":"Kandzari","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2019.11.003_bb0055","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0060","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0065","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI)","volume":"62","author":"Moussa","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0070","series-title":"Survival Analysis: Techniques for Censored and Truncated Data","first-page":"1","author":"Klein","year":"2005"},{"key":"10.1016\/j.ijcard.2019.11.003_bb0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.21037\/atm.2016.08.45","article-title":"Parametric regression model for survival data: Weibull regression model as an example","volume":"4","author":"Zhang","year":"2016","journal-title":"Ann Transl Med."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0080","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","article-title":"Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty","volume":"316","author":"Sigwart","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0085","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J A Col Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0095","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jacc.2011.02.022","article-title":"Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (clinical evaluation of the XIENCE V Everolimus eluting coronary stent system) IV trial","volume":"58","author":"Stone","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/eht542","article-title":"Bioresorbable scaffolds: rationale, current status, challenges, and future","volume":"35","author":"Iqbal","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0110","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jcin.2015.03.029","article-title":"Acute thrombogenicity of a durable polymer everolimus-eluting stent relative to contemporary drug-eluting stents with biodegradable polymer coatings assessed ex vivo in a swine shunt model","volume":"8","author":"Otsuka","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0115","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004762","article-title":"Comparison of acute thrombogenicity for metallic and polymeric bioabsorbable scaffolds: Magmaris versus absorb in a porcine arteriovenous shunt model","volume":"10","author":"Waksman","year":"2017","journal-title":"Circ Cardiovasc Interv."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0120","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.4244\/EIJ-D-17-00958","article-title":"Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model","volume":"14","author":"Lipinski","year":"2019","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.ijcard.2019.11.003_bb0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ejcts\/ezx334","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"53","author":"Valgimigli","year":"2018","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ahj.2014.11.012","article-title":"Suboptimal stent deployment is associated with subacute stent thrombosis: optical coherence tomography insights from a multicenter matched study. From the CLI Foundation investigators: the CLITHRO study","volume":"169","author":"Prati","year":"2015","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2019.11.003_bb0135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ahj.2014.11.002","article-title":"Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents","volume":"169","author":"Garg","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2019.11.003_bb0140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijcard.2017.12.053","article-title":"In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris - DREAMS 2G) in de novo coronary lesions: insights from the BIOSOLVE-II First-In-Man Trial","volume":"255","author":"Garcia-Garcia","year":"2018","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319336095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319336095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:46:11Z","timestamp":1759092371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319336095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":28,"alternative-id":["S0167527319336095"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.11.003","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12\u202fmonths: Pooled patient level analysis from BIOSOLVE II\u2013III and BIOFLOW II trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}